Arthur Redpath

Arthur brings more than 30 years of Animal Health experience, combining veterinary, commercial, and executive leadership expertise. He helps companies translate complex market data into strategic commercial decisions.

Since joining Stonehaven Consulting in 2019, he has been instrumental in developing the firm's data and analytics capabilities, supporting pharmaceutical companies, investors, and industry leaders with market intelligence, forecasting, and commercial insights across the global Animal Health sector.

A graduate of the Royal (Dick) School of Veterinary Studies at the University of Edinburgh, he began his career in veterinary practice and cattle genetics before joining Novartis Animal Health in 2000. Over the following 15 years, he held several senior global leadership positions, including Global Head of the Cattle & Sheep Business and Category Head for Companion Animal Parasiticides. Following the acquisition of Novartis Animal Health, Arthur joined Elanco, where he served as EMEA Chief Marketing Officer and later Global Marketing Excellence Leader, driving commercial excellence, capability building, and strategic alignment across international markets.

Arthur holds the MCIM designation from the Chartered Institute of Marketing (UK) and is a member of the Society for Veterinary Epidemiology & Preventive Medicine.